Introduction
Streptodornase-streptokinase Varidase (R) is a medicament derived from the refined extra-cellular products of a Lancefield group C strain of Streptococcus [1] , where the principal therapeutically active constituents are streptokinase, a plasminogen activator, and a group of deoxyribonucleases collectively described as streptodornase. In the United Kingdom, Varidase is used topically for the treatment of inflammation and the degradation and liquefaction of accumulations of clotted blood and fibrinous and purulent exudates [2] . However, Varidase is also produced as an oral anti-inflammatory, which finds widespread use in a number of countries throughout the world.
The two principal active components of the medicament have separate, but mutually enhancing, roles. Streptokinase activates plasminogen to form plasmin, which causes the breakdown of fibrin resulting in a rapid dissolution ofboth blood clots and the fibrinous portion of the wound exudate [3] . The heating coil. This was of a greater length than the first and was placed in the substrate feed line to pre-heat the substrate DNA to 30C. This ensured that the smaller secondary coil was sufficient to keep the reaction mixture at its optimum temperature.
As a consequence of introducing the dialysis units it became necessary to introduce air segmentation into the sample line. Without segmentation there was considerable mixing of different samples as they entered the dialysers resulting in 'bleed-over' of activity when the samples were read. The addition of the air bubbles prevented this. After passing the dialyser units, the sample line must merge with the main substrate flow, where the presence of the smaller, secondary, air bubbles of the sample stream between the main segmenting bubbles was thought to be reducing the efficiency of the mixing stage which followed. In order to overcome this, the 'h3' connector (Part No. 116-0211) was orientated so that it was in the vertical plane at an angle of approximately 60 from the horizontal (see figure 2) A typical elution profile of the gel filtration of Varidase using Bio-Gel P100 monitored to indicate the presence of proteins is presented in figure 3 . Also shown in figure 3 
